Robeco Institutional Asset Management B.V.
Position in JNJ — Johnson & Johnson
CIK 1418773
ROTTERDAM, P7
Position in JNJ
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$499,332,702
+$78,590,597 QoQ
Shares Held
1,966,109
+14.2% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#100
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $4,134,092,265 across 9 Drug Manufacturers - General names. JNJ ranks #3 (12.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
758,740 | $910,055,594 | |
| 2 | ABBV |
AbbVie Inc.
|
3,565,119 | $897,126,545 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
1,966,109 | $499,332,702 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
3,459,893 | $437,122,881 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
7,244,630 | $417,435,580 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,373,993 | $305,058,100 | |
| 7 | PFE |
Pfizer Inc
|
11,918,197 | $286,990,183 | |
| 8 | AMGN |
Amgen Inc
|
580,049 | $210,047,343 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $499,332,702 | 1,966,109 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $420,742,105 | 1,721,249 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $327,180,085 | 1,580,962 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $329,951,552 | 1,779,482 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $275,745,369 | 1,805,207 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $295,199,180 | 1,780,024 | Shares | Defined | 2025-04-23 | |
| 2024-12-31 | $235,905,011 | 1,631,206 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $225,422,867 | 1,390,984 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $198,085,824 | 1,355,267 | Shares | Defined | 2024-07-23 | |
| 2024-03-31 | $211,324,597 | 1,335,891 | Shares | Defined | 2024-04-24 | |
| 2023-12-31 | $186,973,578 | 1,192,890 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $190,802,783 | 1,225,058 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $250,065,629 | 1,510,788 | Shares | Defined | 2023-07-24 | |
| 2023-03-31 | $242,538,420 | 1,564,764 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $262,410,042 | 1,485,480 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $264,583,083 | 1,619,632 | Shares | Defined | 2022-12-01 | |
| 2022-06-30 | $308,281,261 | 1,736,698 | Shares | Defined | 2022-12-01 | |
| 2022-03-31 | $327,239,244 | 1,846,410 | Shares | Defined | 2022-12-01 | |
| 2021-12-31 | $334,959,678 | 1,958,027 | Shares | Defined | 2022-12-01 | |
| 2021-09-30 | $388,222,582 | 2,403,855 | Shares | Defined | 2022-12-01 | |
| 2021-06-30 | $396,778,431 | 2,408,513 | Shares | Defined | 2022-12-01 | |
| 2021-03-31 | $437,405,691 | 2,661,428 | Shares | Defined | 2022-12-01 | |
| 2020-12-31 | $408,104,438 | 2,593,115 | Shares | Defined | 2022-12-01 | |
| 2020-09-30 | $336,679,316 | 2,261,414 | Shares | Defined | 2021-01-19 | |
| 2020-06-30 | $295,491,474 | 2,101,198 | Shares | Defined | 2021-01-19 | |
| 2020-03-31 | $249,711,514 | 1,904,305 | Shares | Defined | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||